Search - tctmd.com

Displaying 201 - 220 of 242

Sort: Relevancy | Date

Presentation TCT 2015

Case Introduction: A STEMI Patient With Multivessel Disease

Presenter: Thomas Engstroem, Barry D. Rutherford, Henning Kelbæk

October 11, 2015

Presentation TCT 2015

Impact of CTO Revascularization After Primary PCI for AMI: Is This Where the Benefit Lies?

Presenter: Thomas Engstroem, Barry D. Rutherford, David Antoniucci

October 11, 2015

Presentation TCT 2015

Nonculprit Lesions in STEMI Patients With Multivessel Disease: Is the Issue Ischemia or Vulnerable Plaque?

Presenter: Thomas Engstroem, Barry D. Rutherford, David Erlinge

October 11, 2015

Presentation TCT 2015

Should FFR Be Used Routinely in STEMI Patients With Multivessel Disease, and Is It Reliable During the Index and/or Staged Procedures?

Presenter: Thomas Engstroem, Barry D. Rutherford, Colin Berry

October 11, 2015

Presentation TCT 2015

Updated Meta-analysis of Culprit Only vs Complete Revascularization in STEMI: Are We Impacting Death and Reinfarction or Repeat Revascularization Only?

Presenter: Thomas Engstroem, Barry D. Rutherford, Anthony H. Gershlick

October 11, 2015

Presentation TCT 2015

Introduction: A Critical Appraisal of Culprit Only vs Multivessel Intervention in STEMI Targets, Guidance, Data Review, and Future Directions

Presenter: Thomas Engstroem, Barry D. Rutherford, Shamir R. Mehta

October 11, 2015

Presentation TCT 2015

Keynote Lecture: What It Was Like to Discover the Stent: A Personal Journey

Presenter: Marvin L. Woodall, Julio C. Palmaz

October 11, 2015

Presentation TVT 2015

Case Examples: Medtronic Guidance vs Local CT Assessment Explaining the Occasional Discordance

Presenter: Jeffrey J. Popma

June 06, 2015

Presentation TCT 2014

TCT 150: First-in-Man Experience with Transendocardial Injections of Bone Marrow-Derived Mesenchymal Stem Cells in Idiopathic Dilated Cardiomyopathy: The MYOCYTE Trial

Presenter: Marc S. Penn, Andreas M. Zeiher, Warren Sherman, Ricardo Sanz-Ruiz, MD

September 15, 2014

Presentation TCT 2014

Side Cell Population and Valve Function

Presenter: Marc S. Penn, Andreas M. Zeiher, Warren Sherman, Muralidhar Padala

September 15, 2014

Presentation TCT 2014

Enhancement of MSC Function by Chronic Exposure to Hypoxia

Presenter: Marc S. Penn, Andreas M. Zeiher, Warren Sherman, Stephen E. Epstein

September 15, 2014

Presentation TCT 2014

Cellular Nanotechnology in STEMI

Presenter: Marc S. Penn, Andreas M. Zeiher, Warren Sherman, Jonathan Leor

September 15, 2014

Presentation TCT 2014

Direct Flow Medical - Technology Review, Clinical Results (DISCOVER), Case Examples, and Status of the US Clinical Trial

Presenter: E. Murat Tuzcu

September 15, 2014

Presentation TCT 2014

Microvesicles: Multiple Effects of Cord-Blood CD133+ Cells

Presenter: Henricus J. Duckers, Stephen E. Epstein, Marc S. Penn, Wojtek Wojakowski

September 15, 2014

Presentation TCT 2014

Cell Matrix and Endothelial Function: Impact of Hyperglycemia

Presenter: Henricus J. Duckers, Stephen E. Epstein, Marc S. Penn, Elazer R. Edelman

September 15, 2014

Presentation TCT 2014

Enhanced Effects of Primed Peripheral Monocytes

Presenter: Henricus J. Duckers, Stephen E. Epstein, Marc S. Penn, Hyo-Soo Kim

September 15, 2014

Presentation TCT 2014

FFR, CFR and Microvascular Resistance: Frequency and Impact of Discordances

Presenter: Justin E. Davies, Allen Jeremias, Nick E. J. West, Tim P. van de Hoef

September 14, 2014

Presentation BRS 2014

Is strut disruption-discontinuity with BRS a misnomer, myth or reality?

Presenter: Yoshinobu Onuma

July 26, 2014

Presentation TVT 2014

Direct Flow Medical Technology Review, Clinical Results (DISCOVER), and Status of the US Clinical Trial

Presenter: Charles J. Davidson

June 05, 2014

Presentation

Impact of Early vs Late Clopidogrel Discontinuation on Stent Thrombosis Following PCI with First- and Second-Generation DES

Presenter: J.P. Loh

April 11, 2014

Advertisement

Case Introduction: A STEMI Patient With Multivessel Disease

Impact of CTO Revascularization After Primary PCI for AMI: Is This Where the Benefit Lies?

Nonculprit Lesions in STEMI Patients With Multivessel Disease: Is the Issue Ischemia or Vulnerable Plaque?

Should FFR Be Used Routinely in STEMI Patients With Multivessel Disease, and Is It Reliable During the Index and/or Staged Procedures?

Updated Meta-analysis of Culprit Only vs Complete Revascularization in STEMI: Are We Impacting Death and Reinfarction or Repeat Revascularization Only?

Introduction: A Critical Appraisal of Culprit Only vs Multivessel Intervention in STEMI Targets, Guidance, Data Review, and Future Directions

Keynote Lecture: What It Was Like to Discover the Stent: A Personal Journey

Case Examples: Medtronic Guidance vs Local CT Assessment Explaining the Occasional Discordance

TCT 150: First-in-Man Experience with Transendocardial Injections of Bone Marrow-Derived Mesenchymal Stem Cells in Idiopathic Dilated Cardiomyopathy: The MYOCYTE Trial

Side Cell Population and Valve Function

Enhancement of MSC Function by Chronic Exposure to Hypoxia

Cellular Nanotechnology in STEMI

Direct Flow Medical - Technology Review, Clinical Results (DISCOVER), Case Examples, and Status of the US Clinical Trial

Microvesicles: Multiple Effects of Cord-Blood CD133+ Cells

Cell Matrix and Endothelial Function: Impact of Hyperglycemia

Enhanced Effects of Primed Peripheral Monocytes

FFR, CFR and Microvascular Resistance: Frequency and Impact of Discordances

Is strut disruption-discontinuity with BRS a misnomer, myth or reality?

Direct Flow Medical Technology Review, Clinical Results (DISCOVER), and Status of the US Clinical Trial

Impact of Early vs Late Clopidogrel Discontinuation on Stent Thrombosis Following PCI with First- and Second-Generation DES

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content